The Maudsley Prescribing Guidelines in Psychiatry

David Taylor 지음

Wiley-Blackwell 2012년 02월 06일 출간

작품소개

책소개

Helps with complex prescribing needsThe evidence base for drug treatments in psychiatry ranges from meta-analyses andrandomised controlled clinical trials to single case reports, and from NICE guidelines to individual SPCs. Where do you look for information when transferring a patient from one drug to another? Where do you find a clear overview when dealing with a complex patient (e.g, with co-morbid epilepsy or liver disease or HIV infection)? Where can you seek advice on prescribing psychotropics during pregnancy? The Maudsley Prescribing Guidelines in Psychiatry! The leading clinical reference for handling prescribing problems as encountered in daily practice and for formulating prescribing policy.Evidence-based and written by expertsThis book is the essential guide for anyone responsible for prescribing, dispensing or administering drugs for patients with mental health disorders. All the evidence has been reviewed and summarized succinctly by an expert team of psychiatrists and pharmacists.New content and improved formatThis new edition makes greater use of tables and boxes to facilitate quick reference and includes new sections on cytochrome-mediated interactions and psychiatric side effects of non-psychotropic drugs.Clinically relevantChapters address plasma monitoring, schizophrenia, bipolar disorder, depression and anxiety, children and adolescents, substance abuse and special patient groups. Each section has a full reference list. The book covers prescribing drugs outside their licensed indications and their interaction with substances such as alcohol, nicotine and caffeine.Useful for all levels of experienceTrainees will gain important information regarding the rational, safe and effective use of medications for patients with mental illness. Experienced clinicians will find excellent guidance regarding more complex is

목차

Preface ixAcknowledgements xNotes on using The Maudsley Prescribing Guidelines xiNotes on inclusion of drugs xiList of abbreviations xiiChapter 1 Plasma level monitoring of psychotropic drugs and anticonvulsants 1Interpreting sample results 2Chapter 2 Schizophrenia 11Antipsychotic drugs 11Antipsychotic drugs: equivalent doses 13Antipsychotic drugs: minimum effective doses 14Antipsychotic drugs: licensed maximum doses 16New antipsychotic drugs 17Antipsychotic drugs: general principles of prescribing 21National Institute for Health and Clinical Excellence guidelines for the treatment of schizophrenia 22Treatment algorithms for schizophrenia 24Antipsychotic drugs: monitoring of metabolic effects 26Switching antipsychotic drugs because of poor tolerability 31Antipsychotic response: to increase the dose, to switch, to add or just wait &~ what is the right move? 33Speed and onset of antipsychotic drug action 36First-generation antipsychotic drugs: place in therapy 39Antipsychotic drugs: long-acting injections 40Risperidone long-acting injection 44Paliperidone palmitate long-acting injection 47Management of patients on long-term depots: dose reduction 50Combined antipsychotic drugs 51High-dose antipsychotic drugs: prescribing and monitoring 54Negative symptoms in schizophrenia 57Antipsychotic prophylaxis 60Refractory schizophrenia and clozapine 64Clozapine augmentation 66Refractory schizophrenia: alternatives to clozapine 69Clozapine: management of common adverse effects 75Clozapine: uncommon or unusual adverse effects 78Clozapine: serious haematological and cardiovascular adverse effects 80Clozapine, neutropenia and lithium 84Clozapine and chemotherapy 88Clozapine-related hypersalivation 89Guidelines for the initiation of clozapine for patients based in the community 92Omega-3 fatty acids (fish oils) in schizophrenia 96Extrapyra

출판사 서평

“This comprehensive guide presents clinicians with evidence-based information on prescribing psychotropic drugs for mental health … This book will help nurses to be confident, sensitive and informed when discussing medication with patients and relatives, exploring treatment options within their professional teams and liaising with allied health professionals.”& (Nursing Standard, 30 May 2012)

작가정보

저자(글) David Taylor

저자 :

저자 :

저자 :

저자 :

저자 :
저자 :
저자 :
David Taylor is Director of Pharmacy and Pathology at the South London and Maudsley NHS Foundation Trust, and Professor of Psychopharmacology at King-s College London. The lead author of all editions of the Maudsley Prescribing Guidelines, Professor Taylor is the author of several other texts and editor of Therapeutic Advances in Psychopharmacology.Carol Paton is Chief Pharmacist at Oxleas NHS Foundation Trust, London: she is also joint Head of the Prescribing Observatory for Mental Health and an Honorary Research Fellow at Imperial College London.Shitij Kapur is Professor of Schizophrenia, Imaging and Therapeutics and the Dean and Head of School at the Institute of Psychiatry, King's College London.